未登录 分享 收藏
分享 收藏
Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review 同种异体与自体干细胞移植的比较：在多发性骨髓瘤患者首次自体移植后复发后的应用——一项系统综述 Ludwig, Heinz; Bernhard, Sarah; Ikeda, Takashi; Freytes, Cesar O.; Schreder, Martin; Kawamura, Koji; Atsuta, Yoshiko; Takamatsu, Hiroyuki; Vesole, David H.; Hari, Parameswaran; Krainer, Julie; Hinke, Axel 分享 收藏
分享 收藏
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trial 癌症疫苗UV1在计划接受pembrolizumab一线治疗的复发或转移性PD-L1阳性头颈部鳞状细胞癌患者中的耐受性和有效性-随机2期重点试验 Brandt, Anna; Schultheiss, Christoph; Klinghammer, Konrad; Schafhausen, Philippe; Busch, Chia-Jung; Blaurock, Markus; Hinke, Axel; Tometten, Mareike; Dietz, Andreas; Mueller-Richter, Urs; Hahn, Dennis; Alt, Juergen; Stein, Alexander; Binder, Mascha 分享 收藏
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Wortring Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass) Gruenwald, Viktor; Ivanyi, Philipp; Zschaebitz, Stefanie; Wirth, Manfred; Staib, Peter; Schostak, Martin; Dargatz, Philip; Mueller, Lothar; Metz, Michael; Bergmann, Lothar; Steiner, Thomas; Welslau, Martin; Lorch, Anja; Rafiyan, Reza; Hellmis, Eva; Darr, Cristopher; Schuett, Philipp; Meiler, Johannes; Kretz, Thomas; Loidl, Wolfgang; Floercken, Anne; Maenz, Martin; Hinke, Axel; Hartmann, Arndt; Gruellich, Carsten 分享 收藏
分享 收藏
分享 收藏
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)da randomized phase II trial of the AIO pancreatic cancer group Seufferlein, T.; Uhl, W.; Kornmann, M.; Alguel, H.; Friess, H.; Koenig, A.; Ghadimi, M.; Gallmeier, E.; Bartsch, D. K.; Lutz, M. P.; Metzger, R.; Wille, K.; Gerdes, B.; Schimanski, C. C.; Graupe, F.; Kunzmann, V.; Klein, I.; Geissler, M.; Staib, L.; Waldschmidt, D.; Bruns, C.; Wittel, U.; Fichtner-Feigl, S.; Daum, S.; Hinke, A.; Blome, L.; Tannapfel, A.; Kleger, A.; Berger, A. W.; Kestler, A. M. R.; Schuhbaur, J. S.; Perkhofer, L.; Tempero, M.; Reinacher-Schick, A. C.; Ettrich, T. J. 分享 收藏
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer Tintelnot, Joseph; Ristow, Inka; Sauer, Markus; Simnica, Donjete; Schultheiss, Christoph; Scholz, Rebekka; Goekkurt, Eray; von Wenserski, Lisa; Willscher, Edith; Paschold, Lisa; Lorenzen, Sylvie; Riera-Knorrenschild, Jorge; Depenbusch, Reinhard; Ettrich, Thomas J.; Doerfel, Steffen; Al-Batran, Salah-Eddin; Karthaus, Meinolf; Pelzer, Uwe; Hinke, Axel; Bauer, Marcus; Massa, Chiara; Seliger, Barbara; Wickenhauser, Claudia; Bokemeyer, Carsten; Hegewisch-Becker, Susanna; Binder, Mascha; Stein, Alexander 分享 收藏
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel- results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO FOLFIRI联合ramucirumab与紫杉醇联合ramucirumab作为晚期或转移性胃食管腺癌患者的二线治疗，有或没有多西他赛-AIO德国胃癌研究小组II期RAMIRIS研究的结果 Lorenzen, Sylvie; Thuss-Patience, Peter; Pauligk, Claudia; Goekkurt, Eray; Ettrich, Thomas; Lordick, Florian; Stahl, Michael; Reichardt, Peter; Soekler, Martin; Pink, Daniel; Probst, Stefan; Hinke, Axel; Goetze, Thorsten O.; Al-Batran, Salah E. 分享 收藏
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510 Hoegner, Anica; Al-Batran, Salah-Eddin; Siveke, Jens T.; Lorenz, Mario; Bartels, Prisca; Breithaupt, Kirstin; Malfertheiner, Peter; Homann, Nils; Stein, Alexander; Glaeser, Dietrich; Tamm, Ingo; Hinke, Axel; Vogel, Arndt; Thuss-Patience, Peter 分享 收藏
Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217) Stein, A.; Paschold, L.; Tintelnot, J.; Goekkurt, E.; Thuss-Patience, P. C.; Lorenzen, S.; Ettrich, T. J.; Knorrenschild, J. Riera; Jacobasch, L.; Kretzschmar, A.; Kubicka, S.; Al-Batran, S-E.; Reinacher-Schick, A.; Pink, D.; Sinn, M.; Lindig, U.; Hinke, A.; Becker, S. Hegewisch; Binder, M. 分享 收藏
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis Adams, Richard; Goey, Kaitlyn; Chibaudel, Benoist; Koopman, Miriam; Punt, Cornelis; Arnold, Dirk; Hinke, Axel; Hegewisch-Becker, Susanna; de Gramont, Aimery; Labianca, Roberto; Rubio, Eduardo Diaz; Tveit, Kjell Magne; Wasan, Harpreet; Kaplan, Richard; Brown, Louise; Maughan, Tim; Fisher, David 分享 收藏
Final results on efficacy and patient reported outcomes (PRO) of a randomized phase II trial investigating nivolumab switch-maintenance after TKI induction in metastatic clear cell renal cell carcinoma (mRCC) patients (NIVOSWITCH) Darr, C.; Zschaebitz, S.; Ivanyi, P.; Wirth, M.; Staib, P.; Schostak, M.; Mueller, L.; Metz, M.; Bergmann, L.; Steiner, T.; Lorch, A.; Schuett, P.; Rafiyan, M-R.; Hellmis, E.; Hinke, A.; Maenz, M.; Meiler, J.; Kretz, T.; Floercken, A.; Gruenwald, V. 分享 收藏
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients' data from 3 phase III studies 贝伐单抗作为转移性结直肠癌患者的维持治疗: 来自3项III期研究的个体患者数据的荟萃分析 Salvatore, Lisa; Bria, Emilio; Sperduti, Isabella; Hinke, Axel; Hegewisch-Becker, Susanna; Aparicio, Thomas; Le Malicot, Karine; Boige, Valerie; Koeberle, Dieter; Baertschi, Daniela; Dietrich, Daniel; Tortora, Giampaolo; Arnold, Dirk 分享 收藏
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial Lueong, Smiths S.; Herbst, Andreas; Liffers, Sven-Thorsten; Bielefeld, Nicola; Horn, Peter A.; Tannapfel, Andrea; Reinacher-Schick, Anke; Hinke, Axel; Hegewisch-Becker, Susanna; Kolligs, Frank T.; Siveke, Jens T. 分享 收藏
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine plus sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results Sinn, M.; Liersch, T.; Riess, H.; Gellert, K.; Stuebs, P.; Waldschmidt, D.; Lammert, F.; Maschmeyer, G.; Bechstein, W.; Bitzer, M.; Denzlinger, C.; Hofheinz, R.; Lindig, U.; Ghadimi, M.; Hinke, A.; Striefler, J. K.; Pelzer, U.; Bischoff, S.; Bahra, M.; Oettle, H. 分享 收藏
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel - Final results from the phase II RAMIRIS Study of the AIO Thuss-Patience, P. C.; Al-Batran, S-E.; Pauligk, C.; Goekkurt, E.; Ettrich, T. J.; Lordick, F.; Stahl, M.; Reichardt, P.; Soekler, M.; Pink, D.; Probst, S.; Hinke, A.; Gotze, T. O.; Lorenzen, S. 分享 收藏
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma-the randomized phase 2 INTEGA trial (AIO STO 0217) Ipilimumab或FOLFOX联合Nivolumab和曲妥珠单抗治疗先前未经治疗的HER2-positive局部晚期或转移性食管胃腺癌-随机2期INTEGA试验 (AIO STO 0217) Tintelnot, Joseph; Goekkurt, Eray; Binder, Mascha; Thuss-Patience, Peter; Lorenzen, Sylvie; Knorrenschild, Jorge Riera; Kretzschmar, Albrecht; Ettrich, Thomas; Lindig, Udo; Jacobasch, Lutz; Pink, Daniel; Al-Batran, Salah-Eddin; Hinke, Axel; Hegewisch-Becker, Susanna; Nilsson, Sven; Bokemeyer, Carsten; Stein, Alexander 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏.png)
BMC CANCER